Suheung Capsul Asset Resilience Ratio
Suheung Capsul asset resilience ratio. Suheung Capsul (008490) has an Asset Resilience Ratio of 0.99% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Suheung Capsul (008490) liquidity interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Suheung Capsul (2000–2025)
Asset resilience ratio of Suheung Capsul from 2000 to 2025. This chart shows how Suheung Capsul's Asset Resilience Ratio has changed over time. Read Suheung Capsul total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Suheung Capsul's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Suheung Capsul assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩10.52 Billion | 0.99% |
| Total Liquid Assets | ₩10.52 Billion | 0.99% |
Asset Resilience Insights
- Limited Liquidity: Suheung Capsul maintains only 0.99% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Suheung Capsul Industry Peers by Asset Resilience Ratio
Compare Suheung Capsul's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Ajanta Pharma Limited
NSE:AJANTPHARM |
Drug Manufacturers - Specialty & Generic | 14.99% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Porton Fine Chemicals Ltd
SHE:300363 |
Drug Manufacturers - Specialty & Generic | 6.85% |
|
Jubilant Pharmova Limited
NSE:JUBLPHARMA |
Drug Manufacturers - Specialty & Generic | 1.26% |
Suheung Capsul Asset Resilience Ratio by Year (2000–2025)
Suheung Capsul asset resilience ratio by year from 2000 to 2025. The table below shows the annual Asset Resilience Ratio data for Suheung Capsul.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.99% | ₩10.52 Billion ≈ $7.13 Million |
₩1.06 Trillion ≈ $719.12 Million |
-0.11pp |
| 2024-12-31 | 1.10% | ₩11.22 Billion ≈ $7.60 Million |
₩1.02 Trillion ≈ $689.68 Million |
+0.12pp |
| 2023-12-31 | 0.98% | ₩9.71 Billion ≈ $6.58 Million |
₩993.74 Billion ≈ $673.44 Million |
-1.32pp |
| 2022-12-31 | 2.30% | ₩21.30 Billion ≈ $14.43 Million |
₩926.42 Billion ≈ $627.82 Million |
+1.33pp |
| 2021-12-31 | 0.97% | ₩7.85 Billion ≈ $5.32 Million |
₩809.95 Billion ≈ $548.89 Million |
-1.47pp |
| 2020-12-31 | 2.44% | ₩18.68 Billion ≈ $12.66 Million |
₩765.99 Billion ≈ $519.10 Million |
+1.29pp |
| 2019-12-31 | 1.15% | ₩8.14 Billion ≈ $5.51 Million |
₩708.86 Billion ≈ $480.39 Million |
+0.87pp |
| 2018-12-31 | 0.28% | ₩1.78 Billion ≈ $1.21 Million |
₩639.10 Billion ≈ $433.11 Million |
+0.03pp |
| 2017-12-31 | 0.25% | ₩1.49 Billion ≈ $1.01 Million |
₩595.29 Billion ≈ $403.42 Million |
-0.68pp |
| 2016-12-31 | 0.93% | ₩5.43 Billion ≈ $3.68 Million |
₩585.89 Billion ≈ $397.05 Million |
+0.20pp |
| 2015-12-31 | 0.73% | ₩4.05 Billion ≈ $2.74 Million |
₩556.75 Billion ≈ $377.30 Million |
-0.01pp |
| 2014-12-31 | 0.73% | ₩3.60 Billion ≈ $2.44 Million |
₩491.21 Billion ≈ $332.88 Million |
-0.06pp |
| 2013-12-31 | 0.79% | ₩3.69 Billion ≈ $2.50 Million |
₩466.55 Billion ≈ $316.17 Million |
+0.45pp |
| 2012-12-31 | 0.34% | ₩1.60 Billion ≈ $1.08 Million |
₩466.47 Billion ≈ $316.12 Million |
+0.31pp |
| 2011-12-31 | 0.03% | ₩138.40 Million ≈ $93.79K |
₩434.23 Billion ≈ $294.27 Million |
-0.08pp |
| 2010-12-31 | 0.11% | ₩410.00 Million ≈ $277.85K |
₩359.76 Billion ≈ $243.80 Million |
-1.94pp |
| 2009-12-31 | 2.05% | ₩5.23 Billion ≈ $3.54 Million |
₩255.24 Billion ≈ $172.97 Million |
-5.26pp |
| 2008-12-31 | 7.31% | ₩18.75 Billion ≈ $12.71 Million |
₩256.71 Billion ≈ $173.97 Million |
-9.87pp |
| 2007-12-31 | 17.18% | ₩33.02 Billion ≈ $22.38 Million |
₩192.26 Billion ≈ $130.29 Million |
+7.19pp |
| 2006-12-31 | 9.99% | ₩16.42 Billion ≈ $11.13 Million |
₩164.35 Billion ≈ $111.38 Million |
-3.29pp |
| 2005-12-31 | 13.28% | ₩21.00 Billion ≈ $14.23 Million |
₩158.14 Billion ≈ $107.17 Million |
+13.18pp |
| 2003-12-31 | 0.10% | ₩105.34 Million ≈ $71.39K |
₩110.72 Billion ≈ $75.03 Million |
-4.18pp |
| 2002-12-31 | 4.27% | ₩4.88 Billion ≈ $3.31 Million |
₩114.22 Billion ≈ $77.41 Million |
+0.99pp |
| 2001-12-31 | 3.29% | ₩4.01 Billion ≈ $2.72 Million |
₩122.19 Billion ≈ $82.81 Million |
-9.78pp |
| 2000-12-31 | 13.06% | ₩17.12 Billion ≈ $11.60 Million |
₩131.06 Billion ≈ $88.81 Million |
-- |
About Suheung Capsul
Suheung Co., Ltd. engages in produces and sells hard and soft capsules. The company provides solid dosage forms, including hard and soft capsule, tablets, powder, granules; fluidity and concentrated liquids; gummy, sticky and water jellies. It offers medical supplies, such as prescription medicines; over-the-counter drugs comprising antipyretic-analgesics, cold medicine, digestive medicine, liver… Read more